Eris Lifesciences (BOM:540596) 5-Year EBITDA Growth Rate : 10.20% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences 5-Year EBITDA Growth Rate?

Eris Lifesciences's EBITDA per Share for the three months ended in Dec. 2023 was ₹13.19.

During the past 12 months, Eris Lifesciences's average EBITDA Per Share Growth Rate was 22.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Eris Lifesciences was 41.70% per year. The lowest was 8.50% per year. And the median was 19.45% per year.

Competitive Comparison of Eris Lifesciences's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eris Lifesciences's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's 5-Year EBITDA Growth Rate falls into.

Eris Lifesciences 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Eris Lifesciences (BOM:540596) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Eris Lifesciences 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences (BOM:540596) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

ERIS:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines